Diopter Technologies Announces Completed of Clinical Study for Revolutionary Dissolving Amniotic Membrane Biopolymer Contact Lens for Ocular Surface Disease Treatment
Groundbreaking device accelerates healing while eliminating extra office visits BOSTON, MA – July 10, 2025 – Diopter Technologies today announced the completion of early clinical studies of its innovative dissolving amniotic membrane and biopolymer contact lens, a first-of-its-kind therapeutic device designed to treat ocular surface diseases including dry eye syndrome, corneal trauma injuries, and post-surgical […]
